Clinical Trials Logo

Ischemic Stroke clinical trials

View clinical trials related to Ischemic Stroke.

Filter by:

NCT ID: NCT05618535 Completed - Clinical trials for Acute Ischemic Stroke

Effect of Body Position on Hemodynamics in Patients With Acute Ischemic Stroke Undergoing Ultra-early Reperfusion Therapy

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study was to determine the differences in hemodynamics between different positions in patients undergoing ultra-early reperfusion therapy.

NCT ID: NCT05614401 Completed - Clinical trials for Acute Ischemic Stroke

Long-term Outcome of RIPC After IV Thrombolysis in AIS Patients

RESPONTH
Start date: October 28, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about the long-term efficacy of our previous study in acute ischemic stroke(AIS) patients who underwent either remote ischemic postconditioning(RIPC) or sham treatment after intravenous thrombolysis. The main questions it aims to answer are: - Dose the RIPC treatment combined with IV thrombolysis can improve the long-term functional outcome in AIS patients? - Dose the RIPC treatment combined with IV thrombolysis can improve the incidence rates of all-cause and cardiovascular mortality, recurrent stroke/TIA, new-onset clinical AF on this long-term follow-up? A single rater (A.E.P.) trained by an experienced stroke physician (S.T.E.) contacted patients, relatives, and family physicians to gather all available medical information on the following issues: 1) survival status, 2) date of death in those who died (based on information of the treating physicians), 3) mRS score at the time of the interview, 4) recurrent stroke/TIA, 5) new onset atrial fibrillation, 6) other cardiovascular events, including myocardial infarction, pulmonary embolism, deep venous thrombosis, peripheral arteriopathy. Researchers will compare RIPC group and control group to see if the RIPC treatment have a long-term effect in AIS patients.

NCT ID: NCT05612776 Recruiting - Stroke Clinical Trials

HIIT vs HRV-based Training for Rehabilitation After Stroke

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

Consequences of stroke are manyfold but all of them are important factors on the long-term outcomes of rehabilitation, becoming an important health problem with requires health strategies with advanced age. High intensity interval training (HIIT) is an efficient training protocol used in cardiac rehabilitation programs, but owing to the inter-individual variability in physiological responses to training associated to cardiovascular diseases, the exercise dose received by each patient should be closely controlled and individualized to ensure the safety and efficiency of the exercise program. The heart rate variability (HRV) is actually being used for this purpose, as it is closely linked to de parasympathetic nervous system activation. In this way, higher scores in HRV are associated with a good cardiovascular adaptation. The objective of this protocol is to determine the effect of HIIT compared with HRV-guided training on cardiorespiratory fitness, heart rate variability, functional parameters, body composition, quality of life, inflammatory markers, cognitive function, and feasibility, safety and adherence in patients after stroke undertaking an 8-week cardiac rehabilitation program. This will be a cluster-randomized controlled protocol in which patients after stroke will be assigned to an HRV-based training group (HRV-G) or a HIIT-based training group (HIIT-G). HIIT-G will train according to a predefined training program. HRV-G training will depend on the patients' daily HRV. The peak oxygen uptake (VO2peak), endothelial and work parameters, the heart rate variability, the functional parameters, the relative weight and body fat distribution, the quality of life, the inflammatory markers, the cognitive function, and the exercise adherence, feasibility and safety will be considered as the outcomes. It is expected that this HRV-guided training protocol will improve functional performance in the patients after stroke, being more safe, feasible and generating more adherence than HIIT, providing a better strategy to optimize the cardiac rehabilitation interventions.

NCT ID: NCT05611242 Recruiting - Clinical trials for Acute Ischemic Stroke

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

PICASSO
Start date: May 1, 2024
Phase: Phase 3
Study type: Interventional

The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circulation and have a proximal carotid occlusive disease (occlusion or severe stenosis).

NCT ID: NCT05604638 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke

ATTIS
Start date: March 31, 2023
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the safety and efficacy of early administration of tirofiban in patients treated with tenecteplase for acute ischemic stroke.

NCT ID: NCT05602740 Enrolling by invitation - Stroke, Acute Clinical Trials

Detection of hEad Pulse for Ischemic StrOke Verification Study

EPISODE_VS
Start date: June 15, 2023
Phase:
Study type: Observational

Prehospital providers encounter patients with suspected stroke frequently. Prehospital providers need tools to help triage large vessel stroke patients to comprehensive stroke centers. This device will identify large vessel stroke to ultimately improve triage decisions and optimize outcomes.

NCT ID: NCT05600374 Recruiting - Clinical trials for Ischemic Stroke, Acute

Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke

Boss-Stroke
Start date: February 6, 2023
Phase: N/A
Study type: Interventional

We will investigate the therapeutic efficacy of EEG-synchronized noninvasive repetitive transcranial magnetic stimulation (rTMS) in the early subacute phase after ischemic stroke to improve upper limb motor rehabilitation. We hypothesize that synchronization of rTMS with the phase of the ongoing sensorimotor oscillation indicating high corticospinal excitability leads to significantly stronger improvement of paretic upper limb motor function than the same rTMS protocol non-synchronized to the ongoing sensorimotor oscillation or sham stimulation.

NCT ID: NCT05599009 Recruiting - Ischemic Stroke Clinical Trials

Remote Ischemic Conditioning and Dynamic Cerebral Autoregulation in Patients With Intracranial and Extracranial Arteriosclerosis

Start date: December 10, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the effect of remote ischemic conditioning on the dynamic cerebral autoregulation in patients with intracranial and extracranial arteriosclerosis and the changes of dynamic cerebral autoregulation within 24 hours after remote ischemic conditioning.

NCT ID: NCT05598775 Enrolling by invitation - Ischemic Stroke Clinical Trials

Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study

LTFU
Start date: November 1, 2022
Phase:
Study type: Observational

The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival

NCT ID: NCT05592054 Suspended - Clinical trials for Acute Ischemic Stroke

Proximal TEmporary oCclusion Using Balloon Guide Catheter for Mechanical Thrombectomy

PROTECT-MT
Start date: November 20, 2022
Phase: N/A
Study type: Interventional

A multi-center, prospective, randomized, open-label, blinded endpoint assessment (PROBE) clinical trial of endovascular treatment among selected AIS.